Literature DB >> 23406253

Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study.

Martha Kim1, Dong Myung Kim, Ki Ho Park, Tae-Woo Kim, Jin Wook Jeoung, Seok Hwan Kim.   

Abstract

PURPOSE: To investigate whether the amount of intraocular pressure (IOP) reduction with topical medications is associated with the progression of normal-tension glaucoma (NTG) and to identify risk factors for NTG progression.
METHODS: The medical records of 121 eyes of 121 NTG patients, who were treated with topical medications for more than 7 years, were reviewed. NTG progression was defined by either structural (optic disc or retinal nerve fibre layer) or functional (visual field) deterioration. Patients were divided into tertile groups according to the percentage IOP reduction from baseline, and the cumulative probability of NTG progression between upper and lower tertile group was compared using Kaplan-Meier survival analysis. Multivariate analysis with Cox's proportional hazard model was performed to identify the hazard ratio (HR) of clinical factors for NTG progression.
RESULTS: The average follow-up period was 12.2 years, and 56 of 121 eyes (46.3%) showed the NTG progression. Kaplan-Meier analysis revealed that upper tertile group (percentage IOP reduction >22.1%) showed a greater cumulative probability of non-progression than lower tertile group (percentage IOP reduction < 13.3%; p = 0.012). Multivariate Cox's proportional hazard model indicated that percentage reduction of IOP (HR = 0.964; p = 0.007) and the occurrence of disc haemorrhage (HR = 2.410; p = 0.008) were significantly associated with NTG progression.
CONCLUSIONS: The amount of IOP reduction using topical medications was related to NTG progression, and lower percentage reduction in IOP was a consistent risk factor for progression.
© 2013 The Authors. Acta Ophthalmologica © 2013 Acta Ophthalmologica Scandinavica Foundation. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23406253     DOI: 10.1111/aos.12082

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  21 in total

1.  Impact of intraocular pressure reduction on visual field progression in normal-tension glaucoma followed up over 15 years.

Authors:  Shinya Oie; Kyoko Ishida; Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2017-05-26       Impact factor: 2.447

2.  Results of long-term monitoring of normal-tension glaucoma patients receiving medical therapy: results of an 18-year follow-up.

Authors:  Shinya Komori; Kyoko Ishida; Tetsuya Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-17       Impact factor: 3.117

3.  Influence of intraocular pressure reduction on progression of normal-tension glaucoma with myopic tilted disc and associated risk factors.

Authors:  Bo Ram Seol; Soa Kim; Dong Myung Kim; Ki Ho Park; Jin Wook Jeoung; Seok Hwan Kim
Journal:  Jpn J Ophthalmol       Date:  2017-03-09       Impact factor: 2.447

4.  The impact of disc hemorrhage studies on our understanding of glaucoma: a systematic review 50 years after the rediscovery of disc hemorrhage.

Authors:  Tetsuya Yamamoto
Journal:  Jpn J Ophthalmol       Date:  2018-11-21       Impact factor: 2.447

5.  Association of Angle Width With Progression of Normal-Tension Glaucoma: A Minimum 7-Year Follow-up Study.

Authors:  Ahnul Ha; Young Kook Kim; Jin Wook Jeoung; Dong Myung Kim; Ki Ho Park
Journal:  JAMA Ophthalmol       Date:  2019-01-01       Impact factor: 7.389

6.  Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types.

Authors:  Rana N El-Danaf; Andrew D Huberman
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

7.  Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study.

Authors:  Makoto Aihara; Fenghe Lu; Hisashi Kawata; Akihiro Iwata; Noriko Odani-Kawabata
Journal:  Jpn J Ophthalmol       Date:  2021-09-08       Impact factor: 2.447

8.  Prospective 12-month outcomes of combined iStent inject implantation and phacoemulsification in Asian eyes with normal tension glaucoma.

Authors:  Bryan Chin Hou Ang; Wenqi Chiew; Vivien Cherng Hui Yip; Chun Hau Chua; Wei Shan Han; Ivan O'Neill C Tecson; Jeanne Joyce Ogle; Boon Ang Lim; Owen Kim Hee; Elton Lik Yong Tay; Vernon Khet Yau Yong; Hon Tym Wong; Leonard Wei Leon Yip
Journal:  Eye Vis (Lond)       Date:  2022-07-05

9.  Retinal vessel diameter in normal-tension glaucoma patients with asymmetric progression.

Authors:  Tae-Eun Lee; Yong Yeon Kim; Chungkwon Yoo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-12       Impact factor: 3.117

10.  Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma.

Authors:  Keiji Yoshikawa; Shiro Mizoue; Koji Nitta; Hiroshi Onishi; Masaharu Ikeda; Akemi Mizuno; Kaori Kawazoe; Yoshiyuki Tamada; Ryuji Takeda; Shun Matsumoto
Journal:  Clin Ophthalmol       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.